In an MPTP-injected mouse model of PD, α-asarone treatment suppressed glial activation, protected dopaminergic TH-positive neurons in the substantia nigra and TH-positive fibres in the striatum, and attenuated PD-like behavioural impairments, as assessed by the Y-maze and pole tests [25]. The gene discussed is TH; the disease is Parkinson disease.